Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.692 EUR | -0.59% | +3.80% | -36.39% |
04-08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-25 | Advicenne: ODD designation in cystinuria | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.39% | 22.47M | |
-3.35% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+52.98% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-5.15% | 8.3B |
- Stock Market
- Equities
- ALDVI Stock
- News Advicenne
- Advicenne's Distal Renal Tubular Acidosis Drug Receives Orphan Drug Designation in US